Pharma excessive pricing probe spreads to South Africa
South Africa’s antitrust enforcer has opened wide-ranging investigations of Roche, Pfizer and Aspen, accusing the pharmaceutical companies of illegal unilateral conduct affecting the price and availability of cancer drugs.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now